Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.210
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed

Arbutus Biopharma Revenue

Arbutus Biopharma had revenue of $1.34M in the quarter ending September 30, 2024, a decrease of -71.25%. This brings the company's revenue in the last twelve months to $6.74M, down -69.69% year-over-year. In the year 2023, Arbutus Biopharma had annual revenue of $18.14M, down -53.51%.

Revenue (ttm)
$6.74M
Revenue Growth
-69.69%
P/S Ratio
85.86
Revenue / Employee
$92,356
Employees
73
Market Cap
608.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202318.14M-20.88M-53.51%
Dec 31, 202239.02M28.03M255.11%
Dec 31, 202110.99M4.07M58.92%
Dec 31, 20206.91M903.00K15.02%
Dec 31, 20196.01M66.00K1.11%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 811.00M
Ironwood Pharmaceuticals 378.42M
Pharming Group 285.75M
Entrada Therapeutics 215.23M
Butterfly Network 76.22M
Stoke Therapeutics 16.74M
Autolus Therapeutics 10.09M
Revenue Rankings